Main > ENDOCRINOLOGY > Diabetes. Treatment > Peptides. > Peptide ImmunoModulator > Co.: IL. A. (Phase III/Patent)

---

Co.: IL. A. (Phase III/Patent)'s subsections
Clinical Study: EU; IL & South Afri
Company
Diabetes Type-1
Patent>Assignee
TradeMark
UpDate: 06.14.07

Co.: IL. A. (Phase III/Patent)'s products
This section has no products